Genetica Bioscience
Genetica Bioscience specializes in biotechnology, offering biorremediators, bioestimuladores, and water analysis services.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Acquired by AArchiMed on · ARCHIMED.
About Genetica Bioscience
Genetica Bioscience is a company based in Chapecó, Brazil. Recent Funding lists it under Health and bio. Its latest known round is a Series B+ round (October 2026); no sourced amount is on record for it yet. Investors on record for it include Rise. It was acquired by ArchiMed in October 2026.
Funding rounds
- Series B+ · amount undisclosedSource: geneticagroup.com
- Acquired by
AArchiMed
Source: ARCHIMED - Website created
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Genetica Bioscience: questions and answers
- Who invested in Genetica Bioscience?
- Investors on record for Genetica Bioscience: Rise.
- Where is Genetica Bioscience based?
- Genetica Bioscience is based in Chapecó, Brazil.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genetica-bioscience (get a free API key).